Skip to main content
Top
Published in: Annals of Surgical Oncology 5/2013

01-05-2013 | Gastrointestinal Oncology

Practice Patterns for the Management of Hepatic Metastases from Colorectal Cancer: A Mixed Methods Analysis

Authors: Alice C. Wei, MD, Lakhbir Sandhu, MD, Katharine S. Devitt, MSc, Anna R. Gagliardi, PhD, Erin D. Kennedy, MD, David R. Urbach, MD, Steve Gallinger, MD, Nancy N. Baxter, MD

Published in: Annals of Surgical Oncology | Issue 5/2013

Login to get access

Abstract

Purpose

The optimal management of colorectal cancer liver metastases (CRC-LM) has changed during the past two decades. However, clinical practice lags behind best evidence recommendations. We sought to characterize the gap between current practice and best evidence for the management of these patients and to identify barriers that hamper effective utilization of metastasectomy.

Methods

A mixed-methods approach was used. A survey was mailed to all general surgeons (GS) and medical oncologists (MO) in Ontario, Canada. Domains examined included: physician/practice characteristics, indications for hepatectomy, use of multi-modality therapy and referral patterns. Physician focus groups were conducted that explored issues relating to access to care.

Results

The survey was mailed to 942 physicians with a response rate of 68 % (n = 348; GS n = 295, 69 %; MO n = 53, 63 %). Current practice patterns demonstrated that 97 % of physicians refer patients with low tumor burden (e.g., solitary CRC-LM), but referral rates for hepatectomy decreased as the tumor burden increased. Physicians still consider extrahepatic disease as a strong contraindication to metastasectomy. Barriers to care included: economic, time, and resource constraints; lack of physician engagement, local medical expertise, and high-quality guidelines. Multidisciplinary cancer conferences were identified as an enabler of clinical care and a potential platform for the acquisition of new medical knowledge.

Conclusions

Current management of CRC-LM does not reflect best evidence. Patients who may benefit from surgery are not being referred for metastasectomy. We have identified an evidence-practice gap at the level of physician, which should be targeted with novel quality improvement strategies.
Literature
1.
go back to reference Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254–9.PubMedCrossRef Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254–9.PubMedCrossRef
2.
go back to reference Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006;13(5):668–76.PubMedCrossRef Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006;13(5):668–76.PubMedCrossRef
3.
go back to reference Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239(6):818–25.PubMedCrossRef Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239(6):818–25.PubMedCrossRef
4.
go back to reference Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235(6):759–66.PubMedCrossRef Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235(6):759–66.PubMedCrossRef
5.
go back to reference Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol. 2001;8(4):347–53.PubMedCrossRef Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol. 2001;8(4):347–53.PubMedCrossRef
6.
go back to reference Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309–18.PubMedCrossRef Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309–18.PubMedCrossRef
8.
go back to reference McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635–45.PubMedCrossRef McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635–45.PubMedCrossRef
9.
go back to reference Westfall J, Mold J, Fagnan L. Practice-based research—“Blue Highways” on the NIH roadmap. JAMA. 2007;297(4):403–6.PubMedCrossRef Westfall J, Mold J, Fagnan L. Practice-based research—“Blue Highways” on the NIH roadmap. JAMA. 2007;297(4):403–6.PubMedCrossRef
10.
go back to reference Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109(4):718–26.PubMedCrossRef Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109(4):718–26.PubMedCrossRef
11.
go back to reference Sjövall A, Järv V, Blomqvist L, et al. The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study. Eur J Surg Oncol. 2004;30(8):834–41.PubMedCrossRef Sjövall A, Järv V, Blomqvist L, et al. The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study. Eur J Surg Oncol. 2004;30(8):834–41.PubMedCrossRef
12.
go back to reference Ksienski D, Woods R, Caroline S, Kennecke H. Patterns of referral and resection among patients with liver-only metastatic colorectal cancer (MCRC). Ann Surg Oncol. 2010;17:3085–93.PubMedCrossRef Ksienski D, Woods R, Caroline S, Kennecke H. Patterns of referral and resection among patients with liver-only metastatic colorectal cancer (MCRC). Ann Surg Oncol. 2010;17:3085–93.PubMedCrossRef
13.
go back to reference Heriot AG, Reynolds J, Marks CG, Karanjia N. Hepatic resection for colorectal metastases—a national perspective. Ann R Coll Surg Engl. 2004;86(6):420–4.PubMedCrossRef Heriot AG, Reynolds J, Marks CG, Karanjia N. Hepatic resection for colorectal metastases—a national perspective. Ann R Coll Surg Engl. 2004;86(6):420–4.PubMedCrossRef
14.
go back to reference Bujanda L, Sarasqueta C, Zubiaurre L, et al. Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer. Gut. 2007;56(12):1714–8.PubMedCrossRef Bujanda L, Sarasqueta C, Zubiaurre L, et al. Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer. Gut. 2007;56(12):1714–8.PubMedCrossRef
15.
go back to reference National Cancer Institute. Cancer trends progress report—2009/2010 update: colorectal cancer screening. Bethesda: National Cancer Institute, NIH, DHHS; 2010. National Cancer Institute. Cancer trends progress report—2009/2010 update: colorectal cancer screening. Bethesda: National Cancer Institute, NIH, DHHS; 2010.
18.
go back to reference Dillman D, Smyth J, Christian L. Internet, mail, and mixed-mode surveys: the Tailored Design Method. Hoboken: Wiley; 2009. Dillman D, Smyth J, Christian L. Internet, mail, and mixed-mode surveys: the Tailored Design Method. Hoboken: Wiley; 2009.
20.
go back to reference Kruger R, Casey M. In Focus groups: a practical guide for applied research. 3rd ed. Thousand Oaks: Sage Publications, Inc.; 2000. Kruger R, Casey M. In Focus groups: a practical guide for applied research. 3rd ed. Thousand Oaks: Sage Publications, Inc.; 2000.
21.
go back to reference Strauss AL, Corbin JM. Basics of qualitative research: grounded theory procedures and techniques. Newbury Park: Sage Publications; 1990. Strauss AL, Corbin JM. Basics of qualitative research: grounded theory procedures and techniques. Newbury Park: Sage Publications; 1990.
22.
go back to reference Shah SA, Haddad R, Al Sukhni W, et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg. 2006;202(3):468–75.PubMedCrossRef Shah SA, Haddad R, Al Sukhni W, et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg. 2006;202(3):468–75.PubMedCrossRef
23.
go back to reference Adams RB, Haller DG, Roh MS. Improving resectability of hepatic colorectal metastases: expert consensus statement by Abdalla et al. Ann Surg Oncol. 2006;13(10):1281–3.PubMedCrossRef Adams RB, Haller DG, Roh MS. Improving resectability of hepatic colorectal metastases: expert consensus statement by Abdalla et al. Ann Surg Oncol. 2006;13(10):1281–3.PubMedCrossRef
24.
go back to reference D’Angelica M, Brennan MF, Fortner JG, Cohen AM, Blumgart LH, Fong Y. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg. 1997;185(6):554–9.PubMedCrossRef D’Angelica M, Brennan MF, Fortner JG, Cohen AM, Blumgart LH, Fong Y. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg. 1997;185(6):554–9.PubMedCrossRef
25.
go back to reference Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27(22):3677–83.PubMedCrossRef Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27(22):3677–83.PubMedCrossRef
26.
go back to reference Simunovic M, Urbach D, Major D, et al. Assessing the volume-outcome hypothesis and region-level quality improvement interventions: pancreas cancer surgery in two Canadian Provinces. Ann Surg Oncol. 2010;17(10):2537–44.PubMedCrossRef Simunovic M, Urbach D, Major D, et al. Assessing the volume-outcome hypothesis and region-level quality improvement interventions: pancreas cancer surgery in two Canadian Provinces. Ann Surg Oncol. 2010;17(10):2537–44.PubMedCrossRef
27.
go back to reference Sandhu L, Fox A, Nhan C, et al. Assessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario? HPB. 2012;14(6):409–13.PubMedCrossRef Sandhu L, Fox A, Nhan C, et al. Assessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario? HPB. 2012;14(6):409–13.PubMedCrossRef
Metadata
Title
Practice Patterns for the Management of Hepatic Metastases from Colorectal Cancer: A Mixed Methods Analysis
Authors
Alice C. Wei, MD
Lakhbir Sandhu, MD
Katharine S. Devitt, MSc
Anna R. Gagliardi, PhD
Erin D. Kennedy, MD
David R. Urbach, MD
Steve Gallinger, MD
Nancy N. Baxter, MD
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 5/2013
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2698-3

Other articles of this Issue 5/2013

Annals of Surgical Oncology 5/2013 Go to the issue